There is an unmet need for biomarkers in multiple endocrine neoplasia type 1 (MEN1)-related pancreatic neuroendocrine tumors (PanNETs) that allow prediction of clinical behaviour and metastatic potential. The gene discussed is MEN1; the disease is pancreatic neuroendocrine tumor.